NSE
RPG Life Sciences LimitedRPGLIFE
RPG Life Sciences Limited is an NSE-listed company (RPGLIFE).
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Rs 20 Per Share/ Special Dividend - Rs 4 Per Share
ex 2025-06-27
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 3 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 4 | RPGLIFEThis | +₹0 Cr | 2 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — RPGLIFE day by day
- 2026-06-16FilingRPG Life Sciences Limited had intimated the 19-Jun-2026 for the purpose of DI. The Company now cancelled the sCancellation of Book closure
- 2026-06-12FilingSignificant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensurOrder Win
- 2026-06-11FilingSignificant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensurOrder Win
- 2026-06-09FilingCommunication to shareholders - Intimation on dividend Taxation provisionsDividend
- 2026-06-09FilingIntimation to shareholders holding shares in physical form for furnishing KYC detailsGeneral
- 2026-06-09Filing Swallow Associates LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SecurShareholding Disclosure
- 2026-04-30BulkSELL · ₹24.8 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2026-04-30BulkBUY · ₹24.8 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2025-06-27ActionDividend - Rs 20 Per Share/ Special Dividend - Rs 4 Per ShareDividend
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
- 2Cancellation of Book closureNeutral
RPG Life Sciences Limited had intimated the 19-Jun-2026 for the purpose of DI.
Source PDF → - 3
- 3
- 2DividendNeutral
Communication to shareholders - Intimation on dividend Taxation provisions
Source PDF → - 2GeneralNeutral
Intimation to shareholders holding shares in physical form for furnishing KYC details
Source PDF → - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF →
2 deals · 2026-04-30 → 2026-04-30
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2026-04-30 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | SELL | ₹24.8 Cr |
| 2026-04-30 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | BUY | ₹24.8 Cr |
2 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
Calls & transcripts
- Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. RPG Life Sciences Limited has submitted their response. (PDF) →
- Significant increase in volume has been observed in RPG Life Sciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited. (PDF) →
News & chatter on RPGLIFE
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.